Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
DiaMedica Therapeutics Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
|
Security Type |
Security Class Title |
Fee Calculation Rule |
Amount Registered(1) |
Proposed Maximum Offering Price Per Unit(2) |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration Fee |
|
Equity |
Voting Common Shares, no par value per share |
457(c) and 457(h) |
2,000,000 |
$1.61 |
$3,220,000 |
$92.70 per $1,000,000 |
$298.49 |
|
Total Offering Amounts |
$3,220,000 |
$298.49 |
|||||
|
Total Fee Offsets |
$0.00 |
||||||
|
Net Fee Due |
$298.49 |
||||||
|
(1) |
Pursuant to Rule 416 under the Securities Act of 1933, as amended (Securities Act), this registration statement will also cover any additional voting common shares, no par value per share, of the Company (Common Shares) that become issuable under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan by reason of any stock split, stock dividend, recapitalization or other similar transaction effected without the registrant’s receipt of consideration which would increase the number of outstanding Common Shares. |
|
(2) |
Estimated solely for the purpose of calculating the amount of the registration fee and calculated pursuant to Rule 457(c) and Rule 457(h) under the Securities Act on the basis of the average of the high and low sales prices of the Common Shares, as reported by The Nasdaq Capital Market on August 4, 2022. |